Lyra Therapeutics, Inc. (LYRA) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 |
|---|
| Sales/Revenue | 7K | 25K | 183K | 183K | 209K | 195K | 598K | 532K | 146K | 544K | 458K | 410K | 11K | 359K | 525K | 468K | 271K | 14K | 0 | 0 |
| Revenue Growth % | -96.65% | -87.18% | -69.4% | -65.6% | 43.15% | -64.15% | 30.57% | 29.76% | 1227.27% | 51.53% | -12.76% | -12.39% | -95.94% | 2464.29% | - | - | - | - | - | - |
| Cost of Goods Sold | -300K | 100K | 200K | 0 | 0 | 0 | 0 | 136K | 85K | 12.37M | 10.8M | 0 | 12.65M | 0 | 8.99M | 7.8M | 12.04M | 6.38M | 6.41M | 4.77M |
| COGS % of Revenue | -4285.71% | 400% | 109.29% | - | - | - | - | 25.56% | 58.22% | 2273.53% | 2357.86% | - | 115009.09% | - | 1712.95% | 1667.74% | 4443.54% | 45550% | - | - |
| Gross Profit | 307K | -75K | -17K | 183K | 209K | 195K | 598K | 396K | 61K | -11.82M | -10.34M | 410K | -12.64M | 359K | -8.47M | -7.34M | -11.77M | -6.36M | -6.41M | -4.77M |
| Gross Margin % | 4385.71% | -300% | -9.29% | 100% | 100% | 100% | 100% | 74.44% | 41.78% | -2173.53% | -2257.86% | 100% | -114909.09% | 100% | -1612.95% | -1567.74% | -4343.54% | -45450% | - | - |
| Gross Profit Growth % | 46.89% | -138.46% | -102.84% | -53.79% | 242.62% | 101.65% | 105.78% | -3.41% | 100.48% | -3393.59% | -22.12% | 105.59% | -7.38% | 105.64% | -32.21% | -53.82% | -214.48% | -71.42% | - | - |
| Operating Expenses | 6.33M | 6.18M | 8.41M | 9.02M | 11.62M | 12.64M | 49.57M | 23.92M | 16.54M | 5M | 6.16M | 17.72M | 2.52M | 15.19M | 5.93M | 4.59M | 1.87M | 4.72M | 4.66M | 3.06M |
| OpEx % of Revenue | 90471.43% | 24732% | 4596.17% | 4931.15% | 5558.37% | 6480.51% | 8289.63% | 4496.24% | 11327.4% | 919.67% | 1345.41% | 4322.68% | 22863.64% | 4229.81% | 1129.9% | 980.34% | 688.93% | 33700% | - | - |
| Selling, General & Admin | 2.54M | 2.14M | 3.5M | 3.26M | 3.61M | 3.93M | 5.14M | 5.82M | 4.36M | 5M | 4.57M | 5.13M | 1.2M | 5.14M | 5.93M | 4.59M | 1.87M | 4.72M | 4.66M | 3.06M |
| SG&A % of Revenue | 36285.71% | 8544% | 1913.11% | 1783.06% | 1728.71% | 2015.9% | 859.36% | 1093.61% | 2984.25% | 919.67% | 997.82% | 1250.49% | 10900% | 1430.92% | 1129.9% | 980.34% | 688.93% | 33700% | - | - |
| Research & Development | 4.38M | 4.05M | 5.11M | 4.88M | 6.36M | 5.9M | 13.26M | 18.1M | 12.18M | 12.37M | 10.8M | 12.6M | 9.45M | 10.05M | 10.79M | 8.51M | 10.34M | 7.08M | 7.5M | 4.77M |
| R&D % of Revenue | 62542.86% | 16188% | 2792.35% | 2664.48% | 3044.02% | 3026.67% | 2218.06% | 3402.63% | 8343.15% | 2273.53% | 2357.86% | 3072.2% | 85918.18% | 2798.89% | 2055.81% | 1817.31% | 3816.24% | 50550% | - | - |
| Other Operating Expenses | -585K | 0 | -200K | 885K | 1000K | 1000K | 1000K | 0 | 0 | -1000K | -1000K | 0 | -1000K | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -7.5M | -6.26M | -8.43M | -8.84M | -11.41M | -12.44M | -48.97M | -23.52M | -16.48M | -16.83M | -16.5M | -17.31M | -15.15M | -14.83M | -14.4M | -11.93M | -13.64M | -11.08M | -11.06M | -7.83M |
| Operating Margin % | -107071.43% | -25032% | -4605.46% | -4831.15% | -5458.37% | -6380.51% | -8189.63% | -4421.8% | -11285.62% | -3093.2% | -3603.28% | -4222.68% | -137772.73% | -4129.81% | -2742.86% | -2548.08% | -5032.47% | -79150% | - | - |
| Operating Income Growth % | 34.3% | 49.7% | 82.79% | 62.42% | 30.76% | 26.06% | -196.76% | -35.87% | -8.72% | -13.5% | -14.6% | -45.18% | -11.12% | -33.8% | -30.14% | -52.28% | -93.36% | -74.15% | -143.45% | -84.35% |
| EBITDA | -7.39M | -6.16M | -8.23M | -8.71M | -11.26M | -12.4M | -48.83M | -23.39M | -16.39M | -16.76M | -16.37M | -17.03M | -14.93M | -14.55M | -14.11M | -11.64M | -13.36M | -10.73M | -10.76M | -7.76M |
| EBITDA Margin % | -105642.86% | -24632% | -4496.17% | -4761.2% | -5386.12% | -6360.51% | -8165.38% | -4396.24% | -11227.4% | -3081.37% | -3574.78% | -4153.41% | -135754.55% | -4052.09% | -2688.38% | -2488.25% | -4929.89% | -76650% | - | - |
| EBITDA Growth % | 34.31% | 50.35% | 83.15% | 62.75% | 31.33% | 26.01% | -198.24% | -37.34% | -9.77% | -15.23% | -16% | -46.23% | -11.77% | -35.56% | -31.15% | -50.05% | -90.53% | -69.53% | -137.47% | -83.04% |
| D&A (Non-Cash Add-back) | 100K | 100K | 200K | 128K | 151K | 39K | 145K | 136K | 85K | 64.33K | 130.5K | 284K | 222K | 279K | 286K | 280K | 278K | 350K | 303K | 70K |
| EBIT | -6.91M | -5.98M | -7.43M | -7.96M | -9.77M | -9.64M | -17.8M | -23.52M | -16.48M | -16.83M | -14.91M | -17.31M | -13.84M | -14.83M | -14.4M | -11.93M | -13.64M | -11.08M | -11.06M | -7.83M |
| Net Interest Income | 169K | 256K | 410K | 298K | 435K | 576K | 855K | 1.09M | 1.34M | 1.19M | 897K | 1.07M | 933K | 60K | 34K | 14K | 21K | 26K | 26K | 29K |
| Interest Income | 169K | 256K | 410K | 298K | 435K | 576K | 855K | 1.09M | 1.34M | 1.19M | 897K | 1.07M | 933K | 60K | 34K | 14K | 21K | 26K | 26K | 29K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 546K | 277K | 993K | 298K | 435K | 576K | 855K | 1.09M | 1.34M | 1.19M | 897K | 1.07M | 933K | 60K | 34K | 14K | 21K | 26K | 26K | 29K |
| Pretax Income | -6.95M | -5.98M | -7.43M | -8.54M | -10.97M | -11.87M | -48.12M | -22.44M | -15.14M | -15.63M | -15.61M | -16.24M | -14.22M | -14.77M | -14.37M | -11.91M | -13.62M | -11.05M | -11.04M | -7.8M |
| Pretax Margin % | -99271.43% | -23924% | -4062.84% | -4668.31% | -5250.24% | -6085.13% | -8046.66% | -4217.67% | -10369.18% | -2874.08% | -3407.42% | -3961.22% | -129290.91% | -4113.09% | -2736.38% | -2545.09% | -5024.72% | -78964.29% | - | - |
| Income Tax | 2K | 3K | 2K | 4K | 6K | 7K | 12K | 14K | 17K | 16K | 12K | 14K | 13K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -0.03% | -0.05% | -0.03% | -0.05% | -0.05% | -0.06% | -0.02% | -0.06% | -0.11% | -0.1% | -0.08% | -0.09% | -0.09% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -6.95M | -5.98M | -7.44M | -8.55M | -10.98M | -11.87M | -48.13M | -22.45M | -15.16M | -15.65M | -15.62M | -16.25M | -14.23M | -14.77M | -14.37M | -11.91M | -13.62M | -11.05M | -11.04M | -7.8M |
| Net Margin % | -99300% | -23936% | -4063.93% | -4670.49% | -5253.11% | -6088.72% | -8048.66% | -4220.3% | -10380.82% | -2877.02% | -3410.04% | -3964.63% | -129409.09% | -4113.09% | -2736.38% | -2545.09% | -5024.72% | -78964.29% | - | - |
| Net Income Growth % | 36.69% | 49.6% | 84.55% | 61.93% | 27.56% | 24.14% | -208.18% | -38.12% | -6.47% | -5.99% | -8.71% | -36.47% | -4.54% | -33.57% | -30.14% | -52.67% | -93.95% | -74.53% | -143.15% | -84.36% |
| Net Income (Continuing) | -6.95M | -5.98M | -7.44M | -8.55M | -10.98M | -11.87M | -48.13M | -22.45M | -15.16M | -15.65M | -15.62M | -16.25M | -14.23M | -14.77M | -14.37M | -11.91M | -13.62M | -11.05M | -11.04M | -7.8M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -9.60 | -3.38 | -5.51 | -0.13 | -0.17 | -0.18 | -0.73 | -0.35 | -0.25 | -0.27 | -0.36 | -0.44 | -0.45 | -0.40 | -0.42 | -0.92 | -1.05 | -0.85 | -0.85 | -0.60 |
| EPS Growth % | -5547.06% | -1777.78% | -654.79% | 62.86% | 32% | 33.33% | -102.78% | 20.45% | 44.44% | 32.5% | 14.29% | 52.17% | 57.14% | 52.94% | 50.59% | -53.33% | -94.44% | -73.47% | -51.79% | -71.43% |
| EPS (Basic) | -9.60 | -3.38 | -5.51 | -0.13 | -0.17 | -0.18 | -0.73 | -0.35 | -0.25 | -0.27 | -0.36 | -0.44 | -0.45 | -0.40 | -0.42 | -0.92 | -1.05 | -0.85 | -0.85 | -0.60 |
| Diluted Shares Outstanding | 15.53M | 1.77M | 1.35M | 65.76M | 65.11M | 65.46M | 65.46M | 64.01M | 61.53M | 56.95M | 43.68M | 36.83M | 31.83M | 36.83M | 33.95M | 13.01M | 13M | 13M | 12.99M | 12.95M |
| Basic Shares Outstanding | 15.53M | 1.77M | 1.35M | 65.76M | 65.11M | 65.46M | 65.46M | 64.01M | 61.24M | 56.95M | 43.68M | 36.83M | 31.71M | 36.83M | 33.95M | 13.01M | 12.97M | 13M | 12.99M | 12.95M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |